• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Staging and kinetics of multiple myeloma.

作者信息

Durie B G

出版信息

Semin Oncol. 1986 Sep;13(3):300-9.

PMID:3532329
Abstract
摘要

相似文献

1
Staging and kinetics of multiple myeloma.多发性骨髓瘤的分期与动力学
Semin Oncol. 1986 Sep;13(3):300-9.
2
Multiple myeloma.多发性骨髓瘤
Br J Hosp Med (Lond). 2017 Feb 2;78(2):C21-C27. doi: 10.12968/hmed.2017.78.2.C21.
3
Old and new immunophenotypic markers in multiple myeloma for discrimination of responding and relapsing patients: The importance of "normal" residual plasma cell analysis.用于鉴别多发性骨髓瘤缓解期和复发期患者的新旧免疫表型标志物：“正常”残留浆细胞分析的重要性。
Cytometry B Clin Cytom. 2015 May-Jun;88(3):165-82. doi: 10.1002/cyto.b.21218. Epub 2015 Feb 3.
4
Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.
Acta Haematol. 1990;83(3):123-9. doi: 10.1159/000205187.
5
Mass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myeloma.质谱流式细胞术分析表明，一种新型记忆表型B细胞在多发性骨髓瘤中扩增。
Cancer Immunol Res. 2015 Jun;3(6):650-60. doi: 10.1158/2326-6066.CIR-14-0236-T. Epub 2015 Feb 20.
6
Multiple myeloma.多发性骨髓瘤
J R Coll Physicians Lond. 1979 Jul;13(3):146-53.
7
The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.新诊断多发性骨髓瘤患者治疗模式的转变：对护理的启示
Oncol Nurs Forum. 2005 Nov 3;32(6):E127-38. doi: 10.1188/05.ONF.E127-E138.
8
Multiple myeloma.多发性骨髓瘤
Clin Obstet Gynecol. 2002 Sep;45(3):928-38. doi: 10.1097/00003081-200209000-00038.
9
Clinical staging and new therapeutic approaches in multiple myeloma.
Recent Results Cancer Res. 1978;65:12-20. doi: 10.1007/978-3-642-81249-1_3.
10
[Monoclonal antibodies against myeloma cells].[抗骨髓瘤细胞的单克隆抗体]
Nihon Rinsho. 1995 Mar;53(3):580-5.

引用本文的文献

1
Monoclonal Gammopathy of Renal Significance: Histomorphological Spectrum at a Tertiary Care Center.具有肾脏意义的单克隆丙种球蛋白病：三级医疗中心的组织形态学谱
Glomerular Dis. 2022 Aug 4;2(4):153-163. doi: 10.1159/000526244. eCollection 2022.
2
[Analysis of the clinical characteristics and prognosis of 36 cases of newly diagnosed multiple myeloma patients with bone marrow monoclonal plasma cell ratio of less than 10].36例初诊骨髓单克隆浆细胞比例低于10%的多发性骨髓瘤患者临床特征及预后分析
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):295-301. doi: 10.3760/cma.j.issn.0253-2727.2021.04.005.
3
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles.
通过基于基因表达谱的非负矩阵分解方法自动提取基因，提高对 MGUS 和 MM 疾病中骨髓成纤维细胞激活的认识。
J Transl Med. 2018 Aug 3;16(1):217. doi: 10.1186/s12967-018-1589-1.
4
Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients.血清B细胞成熟抗原：一种预测多发性骨髓瘤患者预后的新型生物标志物。
Haematologica. 2017 Apr;102(4):785-795. doi: 10.3324/haematol.2016.150896. Epub 2016 Dec 29.
5
Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy.在接受硼替佐米和/或沙利度胺治疗的多发性骨髓瘤患者中，血清维生素D水平低的情况很常见，且与严重神经病变相关。
Support Care Cancer. 2016 Jul;24(7):3105-10. doi: 10.1007/s00520-016-3126-1. Epub 2016 Feb 23.
6
The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myeloma.使用黑色素瘤抗原基因C1（MAGE C1）和流式细胞术确定多发性骨髓瘤中的恶性细胞类型。
PLoS One. 2015 Mar 20;10(3):e0120734. doi: 10.1371/journal.pone.0120734. eCollection 2015.
7
A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma.一项关于阿莫达非尼治疗多发性骨髓瘤患者癌症相关疲劳的3期试验。
Support Care Cancer. 2015 Jun;23(6):1503-12. doi: 10.1007/s00520-014-2486-7. Epub 2014 Nov 5.
8
A phase II trial of BAY 43-9006 (sorafenib) (NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434.一项针对复发和耐药性多发性骨髓瘤患者的BAY 43-9006（索拉非尼）（NSC-724772）II期试验：SWOG S0434。
Cancer Med. 2014 Oct;3(5):1275-83. doi: 10.1002/cam4.276. Epub 2014 Jun 10.
9
The role of serum protein electrophoresis in the detection of multiple myeloma: an experience of a corporate hospital.血清蛋白电泳在多发性骨髓瘤检测中的作用：一家综合医院的经验
J Clin Diagn Res. 2012 Nov;6(9):1458-61. doi: 10.7860/JCDR/2012/4213.2532.
10
Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4.通过细胞周期偶联的 IRF4 缺失，选择性 CDK4/CDK6 抑制使骨髓瘤细胞早期 G1 期阻滞延长，从而增强其对细胞毒杀伤的敏感性。
Blood. 2012 Aug 2;120(5):1095-106. doi: 10.1182/blood-2012-03-415984. Epub 2012 Jun 20.